Autosomal Recessive Charcot-Marie-Tooth Disease with Focally Folded Myelin Sheaths Type 4B1

Autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin sheaths type 4B1 (usually shortened to CMT4B1) is a very rare inherited nerve disease. It mainly affects the peripheral nerves, which are the long nerves that carry movement and feeling between the brain/spinal cord and the arms and legs. In this disease, the covering of the nerve (called myelin) is damaged and folded in an abnormal way. This makes the nerves work very slowly or not at all. Children usually show symptoms in early childhood, with weakness and wasting of the muscles in the feet and legs, problems walking, and loss of feeling in the feet. Over time, the hands and arms can also be involved. CMT4B1 is caused by damaging changes (mutations) in a gene called MTMR2, and it is passed on in an autosomal recessive pattern. oimd.org+3Genetic Rare Diseases Center+3PubMed+3

Autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin sheaths type 4B1 (often called CMT4B1) is a very rare inherited nerve disease. It happens when both copies of a gene called MTMR2 have harmful changes (mutations). This gene problem leads to damage of the peripheral nerves, the long nerves that carry signals to and from the arms and legs. The myelin (the “insulation” around nerves) becomes abnormal and forms focally folded myelin sheaths, which block smooth nerve signal flow. Children with CMT4B1 usually develop weakness, muscle wasting, and loss of feeling in the feet and hands from early childhood. Many later develop foot deformities like high-arched feet or twisted ankles and may need walking aids or surgery. There is no cure today, but good supportive care can improve movement, comfort, and quality of life. Genetic Rare Diseases Center+2ZFIN+2

---

Other names

Doctors and researchers use several names for this same condition. Knowing these other names can help when reading reports or research papers:

• Charcot-Marie-Tooth disease type 4B1

• CMT4B1

• Autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin sheaths type 4B1

• Charcot-Marie-Tooth neuropathy type 4B1

• Hereditary motor and sensory neuropathy type 4B1 (HMSN 4B1)

• Demyelinating Charcot-Marie-Tooth disease type 4B1

All of these names describe a severe, early-onset form of Charcot-Marie-Tooth disease caused by mutations in the MTMR2 gene and showing the special finding of “focally folded” myelin on nerve biopsy. ZFIN+2Cambridge University Press & Assessment+2

---

Types and clinical patterns

There is one main genetic type of CMT4B1, caused by mutations in the MTMR2 gene. However, doctors sometimes describe clinical patterns or “types” based on how the disease looks in real life. These are not official separate genetic types, but they help explain the range of severity: PubMed+2ScienceDirect+2

1. Early-onset severe pattern – Many children show symptoms in early childhood (often before school age) with marked weakness of the lower legs, very slow nerve conduction, and fast progression of deformities such as high-arched feet and contractures.

2. Childhood-onset moderate pattern – Some children first have problems walking in later childhood, and their symptoms progress more slowly. They may still be able to walk in adulthood but with braces or support.

3. Mild or slowly progressive pattern – A few patients described in the medical literature have a milder course, with symptoms starting in adolescence and slower loss of function, even though they still have MTMR2 mutations and typical myelin folding on nerve biopsy.

4. Lower-limb-dominant pattern – In many cases, weakness and wasting are most obvious in the feet and lower legs for many years, while the hands and arms are less affected at first.

5. Generalized distal neuropathy pattern – With time, the disease often affects both legs and arms, with weakness and muscle loss in feet, legs, hands, and sometimes forearms, causing problems with fine hand tasks such as buttoning or writing.

6. Pattern with marked skeletal deformities – Some individuals develop strong foot deformities (pes cavus, pes equinovarus), curved spine (scoliosis), and chest deformities, mainly because of long-term muscle imbalance and weakness.

These patterns show that, even within one rare disease caused by the same gene, the severity and speed of progression can be different from person to person. Genetic Rare Diseases Center+2MalaCards+2

---

Causes and risk factors

CMT4B1 has one main biological cause – mutations in the MTMR2 gene – but we can break this into several important cause- and risk-related points to understand the disease more clearly. Frontiers+3PubMed+3Europe PMC+3

1. MTMR2 gene mutation (main cause) – CMT4B1 happens when both copies of the MTMR2 gene in a person’s cells have harmful changes (mutations). MTMR2 gives instructions to make a protein that acts as a phosphatase enzyme, helping control special fats in cell membranes, especially in Schwann cells that make myelin around nerves. When MTMR2 is not working, myelin is formed and maintained incorrectly. Frontiers+3PubMed+3Europe PMC+3

2. Autosomal recessive inheritance – The disease follows an autosomal recessive pattern. This means a child must receive one faulty MTMR2 gene from each parent to be affected. Parents usually have one normal and one changed copy and are called “carriers.” They usually do not have symptoms because their remaining normal copy is enough. Muscular Dystrophy Association+2monarchinitiative.org+2

3. Biallelic loss-of-function variants – Most disease-causing mutations in MTMR2 are “loss-of-function” changes. Both copies in the person become non-working, so MTMR2 protein is missing or severely reduced. This loss of function leads directly to the neuropathy and folded myelin. Europe PMC+2oimd.org+2

4. Nonsense or truncating mutations – Some mutations introduce a premature stop signal in the gene (nonsense mutation). This leads to a short, incomplete MTMR2 protein that cannot do its normal job. A recent study reported a novel nonsense mutation that produces a very short protein, completely missing key domains. Dove Medical Press+1

5. Missense mutations – Some mutations change just one amino acid in the protein (missense mutation). Even a single amino acid change at an important site can reduce the enzyme activity or change how the protein folds, and this can be enough to cause CMT4B1 when both copies are affected. PubMed+2Europe PMC+2

6. Loss of phosphatase activity – MTMR2 normally removes phosphate groups from certain phosphoinositide lipids in cell membranes. When MTMR2 is mutated, this phosphatase activity is lost, disturbing lipid balance in Schwann cells. This imbalance contributes to abnormal myelin formation and folding. PubMed+2Rockefeller University Press+2

7. Abnormal membrane homeostasis in Schwann cells – MTMR2 helps keep the cell membrane structure stable and helps with vesicle traffic in Schwann cells. Without MTMR2, membrane recycling is disturbed, and the myelin wraps may grow and fold incorrectly around the nerve fibers. Rockefeller University Press+1

8. Focally folded myelin sheaths – Because of this disturbed membrane control, the myelin sheath does not form smooth layers. Instead, it makes extra loops and foldings in some areas (myelin outfoldings). These folded segments compress or disturb the axon and worsen nerve conduction. Genetic Rare Diseases Center+2Cambridge University Press & Assessment+2

9. Severe demyelinating neuropathy – Over time, the abnormal myelin is lost (demyelination). When myelin is damaged, the nerve signals slow down or block completely, leading to the very slow nerve conduction speeds seen in tests. This demyelination is a direct consequence of MTMR2 dysfunction. Genetic Rare Diseases Center+2MalaCards+2

10. Secondary axonal degeneration – When myelin is severely damaged for many years, the underlying nerve fibers (axons) can also degenerate. This secondary axonal loss contributes to increasing weakness, wasting, and permanent disability. MalaCards+1

11. Genetic “chance” in a carrier couple – If both parents are carriers, there is a 25% chance in each pregnancy that the child will receive both faulty copies and be affected, a 50% chance of being a carrier like the parents, and a 25% chance of receiving two normal copies. The disease does not come from anything the parents did during pregnancy; it comes from this genetic chance pattern. Muscular Dystrophy Association+2arupconsult.com+2

12. Consanguinity (parents related by blood) – In some families, parents are related (for example, first cousins). In these situations, they may share the same rare MTMR2 mutation inherited from a common ancestor. This makes it more likely that a child will receive the same mutation from both parents and develop CMT4B1. Cambridge University Press & Assessment+2ScienceDirect+2

13. Founder mutations in some populations – In certain regions or ethnic groups, one particular MTMR2 mutation may have started in a distant ancestor (“founder mutation”) and then been passed down through many generations, leading to several affected families with the same mutation. Cambridge University Press & Assessment+2ScienceDirect+2

14. Compound heterozygosity – Some patients inherit two different MTMR2 mutations, one from each parent. Each gene copy is faulty in a different way, but together they still cause loss of normal protein function, leading to CMT4B1. arupconsult.com+2mayocliniclabs.com+2

15. Lack of environmental cause – CMT4B1 is not caused by infection, trauma, diet, or toxins. Lifestyle does not create this disease. However, infections or injuries can temporarily worsen symptoms in someone who already has the condition. NCBI+2MedlinePlus+2

16. Genetic heterogeneity within CMT4 group – The CMT4 group includes other subtypes (such as CMT4B2 and CMT4B3) caused by mutations in related myotubularin genes (like MTMR13/SBF2 and others). These conditions share similar mechanisms of myelin folding problems but come from different genes. CMT4B1 is specifically linked only to MTMR2. Cambridge University Press & Assessment+1

17. Effect on both motor and sensory nerves – The same MTMR2 defect affects both motor and sensory Schwann cells, so both movement and sensation nerves are damaged. This dual involvement explains why patients have both weakness and sensory loss. Genetic Rare Diseases Center+2NCBI+2

18. Possible link with male infertility (azoospermia) – MTMR2 is also active in the testis. Animal models and some studies suggest that loss of MTMR2 can cause azoospermia (absence of sperm) in males with CMT4B1, although this is a feature, not a separate cause. It shows how the same mutation can affect different organs. Rockefeller University Press

19. Random new (de novo) mutation – In rare cases, a child may develop a new MTMR2 mutation that is not present in either parent’s blood sample. If the child has two mutated copies (for example, one inherited and one new), this can cause CMT4B1 even without a clear family history. arupconsult.com+2mayocliniclabs.com+2

20. Family history of CMT or unexplained neuropathy – A family with several members showing early neuropathy, foot deformities, or unexplained walking problems may carry MTMR2 mutations without knowing the exact diagnosis. This family history pattern is a practical sign that MTMR2-related CMT4B1 could be the underlying cause. mendelian.co+3NCBI+3ScienceDirect+3

---

Symptoms

Symptoms in CMT4B1 usually start in early childhood and tend to get worse slowly over years. Not every person will have all symptoms, but these are common features reported in studies. mendelian.co+4Genetic Rare Diseases Center+4National Organization for Rare Disorders+4

1. Weakness in the feet and lower legs – One of the first signs is difficulty lifting the front part of the foot (foot drop) and weakness in the ankle muscles. Children may trip often, walk on the outside edges of their feet, or find it hard to run and climb stairs.

2. Muscle wasting (atrophy) in the lower legs – Over time, the muscles in the calves and around the ankles become thin and wasted because the nerves that supply them are damaged. This can make the lower legs look like “inverted champagne bottles,” with thin calves and relatively normal thighs.

3. High-arched feet (pes cavus) – Many patients develop very high arches and sometimes clawed toes. These foot deformities happen because some muscles become weak while others stay stronger, pulling the foot into abnormal positions.

4. Foot deformities such as pes equinovarus – In more severe cases, the foot may point downward and inward (equinovarus). This makes walking even more difficult and can cause pressure sores and pain on parts of the foot that are not made to bear weight.

5. Frequent falls and poor balance – Because muscles are weak and sensation is reduced, patients often have trouble keeping their balance, especially in the dark or on uneven ground. They may fall easily or feel unsteady when turning quickly.

6. Loss of touch and vibration sensation in feet – Sensory nerves are also damaged, so patients may lose fine touch, vibration, and position sense in their toes and feet. They may not feel the floor properly, which adds to balance problems and increases the risk of unnoticed injuries.

7. Numbness or tingling in hands and feet – Many people describe tingling (“pins and needles”), numbness, or burning feelings in their feet and later in their hands. These abnormal sensations are common in sensory neuropathy.

8. Weakness in the hands and lower arms – As the disease progresses, the hands and forearms may also become weak. Patients can have trouble with fine tasks like writing, buttoning clothes, using zippers, or holding small objects.

9. Hand deformities such as claw hands – Long-term weakness in the small muscles of the hands can cause the fingers to curl into a claw-like shape. This happens because some muscle groups weaken more than others, changing the balance of forces on the joints. Genetic Rare Diseases Center+1

10. Absent or reduced tendon reflexes – Reflexes like the knee jerk or ankle jerk are often very weak or absent when tested with a reflex hammer. This is a typical sign of peripheral neuropathy and reflects the damage to both sensory and motor fibers. NCBI+1

11. Slow, progressive course – Symptoms usually get worse very slowly over years. Most people do not have sudden attacks but rather a gradual change. Some may walk independently for many years, while others may need walking aids or a wheelchair earlier. Genetic Rare Diseases Center+2PMC+2

12. Scoliosis and chest deformities – In some severe cases, long-term muscle imbalance and weakness in trunk muscles can lead to a curved spine (scoliosis) or changes in the shape of the chest. These deformities can sometimes affect breathing and posture. Genetic Rare Diseases Center+1

13. Foot pain and joint pain – Abnormal foot shape and unstable joints can lead to pain in the feet, ankles, and knees. Pain may come from pressure points on the sole, tight tendons, or secondary arthritis in overloaded joints. NCBI+2MedlinePlus+2

14. Fatigue and reduced endurance – Because walking and standing require extra effort from weakened muscles, people with CMT4B1 often feel tired easily. Everyday tasks that involve standing, walking, or using the hands may be exhausting. NCBI+2ScienceDirect+2

15. Emotional and social impact – Living with a visible disability, using braces or a wheelchair, and struggling with daily tasks can cause sadness, anxiety, or low self-esteem. Support from family, therapists, and patient groups is important to help cope with these emotional challenges. ScienceDirect+2arupconsult.com+2

---

Diagnostic tests

Diagnosing CMT4B1 usually requires a mix of clinical examination, electrodiagnostic tests, genetic tests, and sometimes nerve biopsy. Below are 20 important tests and evaluations, grouped into physical exam, manual tests, lab/pathological tests, electrodiagnostic tests, and imaging tests. www.elsevier.com+4NCBI+4ScienceDirect+4

Physical exam tests

1. General neurological examination – A neurologist carefully checks muscle strength, tone, sensation (touch, pain, vibration), and reflexes in the arms and legs. In CMT4B1, they usually find distal weakness, muscle wasting, loss of vibration and position sense in the feet, and very reduced or absent tendon reflexes. This exam gives the first strong clue that there is a chronic sensorimotor neuropathy. NCBI+1

2. Gait and balance assessment – The doctor watches how the patient walks, turns, and stands. They look for foot drop, high-stepping gait, ankle instability, and difficulty walking on heels and toes. Problems with tandem walking (heel-to-toe) or standing with feet together may show balance issues from both weakness and sensory loss. NCBI+2MedlinePlus+2

3. Inspection of feet, hands, and legs – The doctor looks closely at the shape of the feet (high arches, claw toes, valgus or varus deformity), the hands (clawing, muscle wasting), and the calves. In CMT4B1, marked foot deformities and thin lower legs are common, and these physical signs help distinguish hereditary neuropathy from other causes. Genetic Rare Diseases Center+2MalaCards+2

4. Spine and chest evaluation – The examiner checks the back and chest for scoliosis and chest wall deformities, which can appear in more severe cases. They also observe posture and breathing pattern. These findings support long-standing neuromuscular disease and may influence decisions about orthopedic or respiratory support. Genetic Rare Diseases Center+2MalaCards+2

5. Functional mobility assessment – The clinician may time how long it takes to stand up from a chair, walk a short distance, or climb steps. These simple timed tests help measure disease severity and follow changes over time, and they show how the nerve damage is affecting everyday life. PMC+1

Manual (bedside) tests

6. Manual muscle testing (MRC grading) – The doctor tests strength in specific muscles by pushing against the patient’s effort and grading it on a standard scale (Medical Research Council scale). In CMT4B1, distal muscles in the feet and hands often score lower than proximal muscles. These detailed strength scores guide physiotherapy and orthotic planning. NCBI+2arupconsult.com+2

7. Romberg test for balance – The patient stands with feet together and eyes open, then closed. If they sway more with eyes closed, it suggests loss of position sense from sensory neuropathy. In CMT, a positive Romberg test is common and reflects the sensory component of the disease. NCBI+2MedlinePlus+2

8. Heel-toe and tandem walking tests – The patient is asked to walk on heels, on toes, and in a straight line with one foot in front of the other. Difficulty with these tasks shows weakness of ankle muscles and impaired balance. This is a simple way to show functional impact of distal neuropathy. NCBI+2arupconsult.com+2

9. Hand function tests – Bedside tasks such as picking up coins, buttoning a shirt, or writing a short sentence help assess fine motor control. In CMT4B1 with hand involvement, these tasks become slow and clumsy, showing how much the neuropathy affects daily living. NCBI+2ScienceDirect+2

10. Sensory mapping with simple tools – The doctor may use cotton, a pin, tuning fork, or monofilament to test light touch, pain, vibration, and pressure at different points. In CMT4B1, reduced sensation in a “stocking-glove” pattern is typical, confirming a length-dependent peripheral neuropathy. NCBI+2MedlinePlus+2

Lab and pathological tests

11. Basic blood tests to rule out other causes – Tests for blood sugar, vitamin B12, thyroid function, kidney and liver function, and autoimmune markers help rule out acquired causes of neuropathy. In CMT4B1, these tests are usually normal, which supports an inherited neuropathy when symptoms and family history match. ScienceDirect+2arupconsult.com+2

12. Targeted MTMR2 genetic testing – If CMT4B1 is strongly suspected, a molecular test can look specifically for pathogenic variants in the MTMR2 gene. Finding two harmful variants confirms the diagnosis and may allow carrier testing and genetic counseling for family members. Invitae+2Europe PMC+2

13. CMT gene panel testing – Because many genes can cause Charcot-Marie-Tooth disease, many centers use next-generation sequencing panels that test dozens of CMT-related genes at once, including MTMR2. This approach is efficient when the exact subtype is not clear from clinical signs alone. arupconsult.com+2mayocliniclabs.com+2

14. Whole-exome sequencing – In very complex cases or families where standard panels are negative, doctors may order whole-exome sequencing. This tests most protein-coding genes and can find rare or novel MTMR2 mutations that were not covered in older panels. It is especially useful in research settings or for very rare presentations. Dove Medical Press+2arupconsult.com+2

15. Sural nerve biopsy with electron microscopy – In some patients, a nerve biopsy from the sural nerve in the leg is done. Under the microscope, doctors look for the typical pattern of focally folded myelin outfoldings and demyelination. This pathological picture is highly characteristic of CMT4B and supports an MTMR2-related diagnosis, especially when genetic testing is not yet available. mendelian.co+3Genetic Rare Diseases Center+3Cambridge University Press & Assessment+3

Electrodiagnostic tests

16. Nerve conduction studies (NCS) – Electrodes are placed on the skin over nerves and small electric shocks are delivered to see how fast and how strongly the nerves conduct signals. In CMT4B1, motor and sensory nerve conduction velocities are very slow or sometimes not recordable, showing a severe demyelinating neuropathy. This is one of the key objective findings in the disease. monarchinitiative.org+3Genetic Rare Diseases Center+3NCBI+3

17. Electromyography (EMG) – A fine needle electrode is inserted into muscles to record electrical activity. EMG helps show whether muscles are denervated (losing nerve supply) and distinguishes neuropathic patterns from muscle diseases. In CMT4B1, EMG usually shows chronic neurogenic changes, reflecting long-standing nerve damage. NCBI+2ScienceDirect+2

18. Late response studies (F-waves and H-reflexes) – Special parts of nerve conduction testing check long loops of nerve pathways. In severe demyelinating neuropathy such as CMT4B1, F-waves and H-reflexes are often delayed or absent, confirming that the problem involves long peripheral nerve segments. NCBI+2arupconsult.com+2

Imaging tests

19. Spinal and brain MRI (to exclude other causes) – MRI of the spine and brain is usually normal in CMT4B1 but may be used to rule out other conditions, such as spinal cord disease or brain lesions, when the diagnosis is unclear. A normal MRI in the presence of clear peripheral neuropathy signs supports a primary peripheral nerve disorder like CMT. ScienceDirect+1

20. Imaging of peripheral nerves (ultrasound or MRI) – In some centers, ultrasound or MRI of peripheral nerves can show thickened or structurally abnormal nerves in hereditary neuropathies. While this is not yet standard for CMT4B1, it can provide extra structural information and may help in research or in complex diagnostic cases. arupconsult.com+1

Non-pharmacological treatments (therapies and other supportive care)

Below are 20 key non-drug approaches. In real life, a specialist team chooses and combines them for each person.

1. Individualized physical therapy program
   A physiotherapist designs a gentle exercise plan that focuses on stretching tight muscles, strengthening weak ones, and training balance and walking. Simple activities like cycling in place, pool exercises, or slow walking may be used. The plan is usually done several times per week and adjusted over time. The main goal is to keep joints moving, maintain as much strength as possible, and reduce pain and stiffness in a safe way. Mayo Clinic+2Muscular Dystrophy Association+2

2. Balance and gait (walking) training
   Because CMT4B1 damages nerves that help with position sense, people often feel unsteady and trip easily. A therapist can train balance using simple tasks such as standing with feet close together, stepping over small objects, and practicing turning safely. Gait training may include learning to lift the feet higher, use correct posture, and coordinate arms and legs. This helps reduce falls and makes everyday walking safer and more energy-efficient. MDPI+2Physiopedia+2

3. Stretching to prevent contractures
   Weak muscles and abnormal pulling on joints can lead to contractures, where joints become stiff and fixed in a bad position. Daily gentle stretches for ankles, knees, hips, and fingers help keep the range of motion. Stretches are held for many seconds and never forced. Caregivers can be taught to help children stretch safely. This simple daily habit can delay or reduce the need for surgery and keep walking easier for longer. nhs.uk+1

4. Strength training with low resistance
   Light resistance exercises, such as using elastic bands or small weights, can help maintain remaining muscle strength without over-fatiguing weak muscles. A therapist chooses safe movements that avoid sudden, jerky efforts. The purpose is to slow down muscle loss, improve function like standing from a chair, and make daily tasks easier. Over-training is avoided, because very tired muscles in neuropathy may need extra time to recover. ScienceDirect+1

5. Ankle-foot orthoses (AFOs)
   AFOs are plastic or carbon braces worn in the shoes and around the ankles. They hold the ankle in a more normal position and help lift the foot during walking. This reduces foot drop, tripping, and ankle sprains. Many people with CMT benefit from AFOs, especially when weakness of the front-of-leg muscles is strong. Good fitting by an orthotist is important so that braces are supportive but still comfortable. nhs.uk+2Physiopedia+2

6. Custom shoes and insoles
   Special shoes or insoles can support unstable ankles, cushion sensitive soles, and fit around high-arched or twisted feet. Extra-deep shoes, strong heel counters, or rocker soles can make walking smoother and less painful. Insoles may correct mild deformities or distribute pressure more evenly to avoid skin breakdown. Shoe changes can greatly improve everyday mobility and reduce fatigue together with braces. nhs.uk+1

7. Walking aids (cane, crutches, walker)
   If balance is poor or falls are frequent, walking aids can make movement safer. A cane, elbow crutches, or a walker provides extra contact points with the ground so the body is less likely to tip. A therapist teaches correct use: correct height, which side to hold the cane, and how to climb stairs safely. Good lighting at home and anti-slip flooring also help. Mayo Clinic+1

8. Wheelchair or scooter for long distances
   Some people with severe CMT4B1 fatigue quickly or have major foot deformities. A wheelchair or power scooter may be used for long distances outside or for days when walking is unsafe or too painful. Using a wheelchair does not mean the person will never walk again; it is a tool to save energy, protect joints, and prevent falls, so that important activities like school or work remain possible. nhs.uk+1

9. Occupational therapy for hands and daily living
   CMT4B1 can weaken hand muscles, making writing, buttoning, and cooking hard. An occupational therapist suggests adaptive tools like thick pen grips, button hooks, Velcro closures, and kitchen aids. They also teach energy-saving strategies, such as sitting for tasks and planning rest breaks. This support helps people remain independent and reduces frustration in daily life. nhs.uk+2Mayo Clinic+2

10. Hand splints and wrist supports
    Splints for the fingers, thumbs, or wrists can position joints in a more useful and less painful posture. They may be worn during writing, typing, or at night to avoid contractures. Good splints can improve grip, reduce tremor, and lessen hand fatigue. They are usually custom-made and adjusted over time as the condition changes. nhs.uk+1

11. Respiratory and postural management (in severe cases)
    In some severe early-onset CMT forms, trunk and breathing muscles may become weak. Regular monitoring of lung function and posture is important. Simple breathing exercises, supported sitting positions, and sometimes non-invasive ventilation at night may be needed. Correct posture in wheelchairs or chairs reduces spine curvature and improves breathing capacity. PMC+1

12. Pain management education (non-drug)
    Non-drug pain strategies can include heat or cold packs to painful joints (with care in people with low feeling), relaxation breathing, mindfulness techniques, and pacing of activity. Learning to balance rest with movement and to avoid sudden overuse can reduce both joint pain and nerve pain. Psychologists or pain specialists can teach these methods and support coping. ScienceDirect+1

13. Psychological support and counseling
    Living with a rare, lifelong condition can cause anxiety, sadness, or feelings of isolation. Talking with a psychologist, counselor, or support group allows people and families to share worries and learn coping skills. Good mental health care can improve motivation for exercise, treatment follow-up, and overall quality of life. ScienceDirect+1

14. School and workplace accommodations
    Children may need extra time for walking between classes, elevators, or adapted physical education. Adults may need ergonomic chairs, voice-to-text software, or flexible schedules. Disability laws in many countries support reasonable adjustments so that people with CMT4B1 can study and work safely and productively. Muscular Dystrophy Association+1

15. Home safety adaptations
    Simple changes at home can prevent falls: grab bars in bathrooms, non-slip mats, removing loose rugs, good lighting, and stair rails. Raised toilet seats or shower chairs can help people with weak legs or poor balance. These low-cost modifications protect fragile joints and make self-care easier. nhs.uk+1

16. Foot care and podiatry
    Because feeling in the feet may be reduced, small cuts or pressure spots can go unnoticed and become ulcers. Regular checks by a podiatrist, proper nail cutting, and daily self-inspection of the feet are important. Correct footwear and early treatment of calluses or sores reduce infection risk and keep walking more comfortable. nhs.uk+1

17. Weight management and general fitness
    Extra body weight makes walking harder, increases joint load, and worsens fatigue. Eating a balanced diet and doing safe low-impact exercise like swimming or cycling help maintain a healthy weight. Good fitness also supports heart and lung health, which is important for people who already struggle with movement. nhs.uk+1

18. Avoidance of neurotoxic medicines
    Some medicines are known to damage peripheral nerves or worsen neuropathy. In people with CMT, these drugs should be avoided or used only with strong reasons. Specialist groups publish lists of drugs that need caution in CMT, and neurologists usually check new medicines against these lists. nhs.uk+1

19. Genetic counseling for patients and families
    Because CMT4B1 is autosomal recessive, parents are usually healthy carriers and each child has a defined chance of being affected. A genetic counselor explains how the gene is passed on, options for family planning, and possibilities for prenatal or pre-implantation genetic diagnosis where available. This helps families make informed decisions and reduce fear and confusion. ZFIN+1

20. Participation in registries and clinical research
    Joining rare disease registries, natural history studies, or treatment trials supports research and may offer access to new therapies. Participation is voluntary and must be carefully discussed with doctors. While research may not give direct benefit, it improves future care for everyone with CMT4B1. MDPI+2ResearchGate+2

---

Drug treatments

Important safety note: No medicine is currently approved specifically to cure CMT4B1. Drug treatment is mainly for symptoms such as neuropathic pain, muscle spasms, mood problems, or sleep disturbance. All medicines below must be prescribed and monitored by a neurologist or other doctor. Doses must follow official FDA labels and be adjusted to the individual; no one should start, stop, or change medicines on their own. MDPI+1

1. Gabapentin (Neurontin and related brands)
   Gabapentin is an anti-seizure drug widely used for neuropathic pain such as post-herpetic neuralgia and diabetic neuropathy. It calms over-active pain nerves by binding to calcium channel subunits and reducing release of excitatory neurotransmitters. In CMT4B1, doctors sometimes use it (off-label) to reduce burning, shooting, or electric shock–like pain in feet and legs. FDA labels describe approved dose ranges and common side effects like dizziness and sleepiness; the dose is slowly increased under medical supervision. FDA Access Data+1

2. Pregabalin (Lyrica, Lyrica CR)
   Pregabalin is related to gabapentin and is approved for several neuropathic pain conditions. It decreases abnormal firing of damaged nerves by modulating calcium channels. In CMT, it may be used to manage nerve pain, improve sleep, and sometimes reduce anxiety related to chronic pain. Doctors choose a daily dose within the FDA-approved range, usually given in two or three divided doses, and monitor for dizziness, weight gain, and swelling. FDA Access Data+3FDA Access Data+3FDA Access Data+3

3. Duloxetine (Cymbalta)
   Duloxetine is a serotonin-noradrenaline reuptake inhibitor (SNRI) approved for depression, anxiety, and certain chronic pain conditions, including neuropathic pain and musculoskeletal pain. It works by boosting pain-modulating chemical signals in the brain and spinal cord so that pain signals from the body are dampened. In CMT-related neuropathic pain, duloxetine can lessen continuous burning pain and improve mood. FDA labeling provides dose ranges; typical side effects include nausea, dry mouth, and sleep changes. FDA Access Data+3FDA Access Data+3FDA Access Data+3

4. Amitriptyline (tricyclic antidepressant)
   Amitriptyline is a tricyclic antidepressant often used in low doses for nerve pain. It affects multiple neurotransmitter systems, including serotonin and noradrenaline, and also blocks certain sodium channels in pain pathways. In CMT, it may be tried at bedtime to reduce pain and improve sleep. Because of possible side effects, such as dry mouth, constipation, heart rhythm changes, and sleepiness, doctors start with very low doses and increase carefully according to FDA guidance. FDA Access Data+1

5. Venlafaxine or other SNRIs
   Venlafaxine is another SNRI antidepressant sometimes used for chronic neuropathic pain. It increases serotonin and noradrenaline in pain control pathways, similar to duloxetine. In people with CMT and co-existing anxiety or depression, venlafaxine may help both mood and pain. Dosing follows label instructions, with monitoring for blood pressure changes, withdrawal symptoms if stopped too fast, and other side effects like nausea.

6. Carbamazepine and related sodium-channel blockers
   Carbamazepine is an anti-seizure drug used for nerve pain like trigeminal neuralgia. It stabilizes inactivated sodium channels and reduces rapid firing in over-excited nerves. In some CMT patients with shooting pain, doctors may try sodium channel blockers such as carbamazepine or oxcarbazepine. Careful monitoring is required because of possible liver, blood, and skin side effects, as described in FDA labeling.

7. Lamotrigine (Lamictal, Lamictal XR)
   Lamotrigine is another anti-seizure medicine that blocks voltage-gated sodium channels and modulates glutamate release. While not a first-line neuropathic pain drug, it may be considered when other options fail or when epilepsy is also present. It must be started very slowly to reduce the risk of serious skin rashes such as Stevens–Johnson syndrome, which is strongly stressed in FDA warnings. FDA Access Data+2FDA Access Data+2

8. Baclofen (oral)
   Baclofen is a muscle relaxant acting mainly on GABA-B receptors in the spinal cord to reduce spasticity and muscle spasms. CMT4B1 usually causes flaccid weakness, not spasticity, but in some people with painful cramps or secondary spinal problems it may be used. FDA labels describe dosing schedules and important risks such as drowsiness and withdrawal reactions if stopped suddenly. FDA Access Data+3FDA Access Data+3FDA Access Data+3

9. Topical lidocaine 5% patch (Lidoderm and generics)
   Lidocaine 5% patches deliver local anesthetic through the skin to quiet pain fibers in a limited area. They are FDA-approved for post-herpetic neuralgia but are often used off-label for focal neuropathic pain. In CMT, they can be placed over especially painful spots, such as part of the foot, to reduce pain without many whole-body side effects. Labels emphasize use only on intact skin and warn about excessive dosing over large areas. FDA Access Data+3FDA Access Data+3FDA Access Data+3

10. Capsaicin 8% patch (Qutenza)
    The capsaicin 8% patch provides a very high dose of capsaicin to the skin. It activates TRPV1 pain receptors so strongly that local nerve endings become less sensitive for weeks. It is FDA-approved for some neuropathic pain conditions such as post-herpetic neuralgia and diabetic neuropathy. In specialized centers, it may be used off-label for difficult focal neuropathic pain in CMT. Application must be done by trained staff, as FDA documents highlight precautions for accidental exposure and skin irritation. PMC+4FDA Access Data+4FDA Access Data+4

(There are many other medicines for pain, sleep, mood, and spasm. The exact combination for CMT4B1 should always be chosen and adjusted only by a neuromuscular specialist, not by the patient alone.)

---

Dietary molecular supplements

Currently, no supplement has been proven to cure CMT4B1, and evidence is limited. Some nutrients support general nerve and muscle health. Any supplement should be checked with a doctor to avoid interactions or overdose.

1. Vitamin B12 (cobalamin)
   Vitamin B12 is vital for healthy myelin and DNA synthesis. True B12 deficiency can cause neuropathy. In people with CMT4B1, doctors may check levels and treat deficiency with oral or injection B12. The purpose is to remove any extra reversible nerve damage on top of the genetic problem. The mechanism is support of myelin repair and normal nerve function.

2. Vitamin B1 (thiamine) and B6 (pyridoxine) – carefully dosed
   Thiamine and pyridoxine help convert food into energy and support nerve conduction. If dietary intake is poor, low-dose B-complex supplements may be used to prevent deficiency. However, high doses of vitamin B6 can itself cause neuropathy, so medical supervision is needed. The functional goal is to optimize nerve metabolism, not to “over-boost” it.

3. Alpha-lipoic acid
   Alpha-lipoic acid is an antioxidant that has been studied mainly in diabetic neuropathy. It may reduce oxidative stress in nerves and improve blood flow. In CMT, evidence is weaker, but some doctors consider it as an adjunct for painful neuropathy. Typical oral doses used in studies are decided by clinicians, and side effects can include stomach upset or low blood sugar in some people.

4. Omega-3 fatty acids (EPA/DHA)
   Omega-3 fats from fish oil support cell membranes and may reduce inflammation. In general neurology, they are thought to help maintain brain and nerve health. In CMT4B1, they will not correct the gene problem but may support overall cardiovascular health and joint comfort, which indirectly helps mobility. Doses are usually based on total EPA/DHA content and balanced against bleeding risk.

5. Vitamin D
   Vitamin D is important for bone strength and muscle function. Limited mobility and staying indoors may lead to low vitamin D levels. Correcting deficiency with doctor-guided supplementation can reduce fracture risk and improve muscle performance, making walking and exercise safer. Blood tests guide dose to avoid toxicity.

6. Coenzyme Q10
   Coenzyme Q10 is part of the energy-producing machinery in mitochondria. It has been explored in various neuromuscular conditions. In CMT, high-quality evidence is limited, but some clinicians try it to support muscle energy and reduce fatigue. The mechanism is to improve mitochondrial function; doses and duration are based on general neuromuscular practice.

7. Magnesium
   Magnesium supports nerve and muscle function and may help with cramps in some people. A doctor may recommend supplementation if blood magnesium is low or if diet is poor. Too much magnesium can cause diarrhea or, in kidney disease, more serious problems, so medical supervision is important.

8. Folate (folic acid)
   Folate works together with B12 in DNA and myelin synthesis. In people with poor diet or absorption problems, folate deficiency can worsen anemia and possibly nerve function. Supplementation is considered if levels are low, with careful dosing and monitoring, especially if vitamin B12 status is not yet known.

9. Creatine monohydrate (with caution)
   Creatine helps muscles store high-energy phosphate. In some neuromuscular diseases, creatine has been studied to slightly improve strength. For CMT, evidence is limited and mixed. A neurologist or dietitian may consider a trial in selected patients, balancing potential small strength gains against possible weight gain and kidney concerns.

10. Multivitamin tailored by a dietitian
    Rather than many single supplements, some people use a balanced multivitamin/mineral under professional guidance. The purpose is to fill small dietary gaps, not to mega-dose. A dietitian can choose a product without excessive levels that might be harmful. Good food remains more important than pills.

---

Regenerative, immunity-boosting, and stem-cell-related drugs

At present, there are no approved stem-cell or gene-therapy drugs for CMT4B1 in routine clinical practice. Research is active, but therapies remain experimental.

1. Gene therapy targeting MTMR2 (experimental)
   Since CMT4B1 is caused by mutations in MTMR2, gene therapy aims to deliver a healthy copy of the gene to nerve cells using viral vectors. Animal models and early lab work show that correcting the gene can improve myelin structure. However, no approved human treatment exists yet, and trials for other CMT types, such as CMT1A or CMT2S, are still in early stages. MDPI+2AFM Téléthon+2

2. Neurotrophic growth factor–based approaches (research)
   Proteins such as neurotrophin-3, nerve growth factor, and others can support nerve survival and regrowth. Studies in CMT models show that these factors may improve axon health, but giving them safely and effectively to humans has been challenging. Newer strategies use gene delivery to make the body produce these factors at controlled levels. These are research tools, not standard treatments. ACMT-Rete+1

3. Stem-cell–derived nerve support cells (preclinical)
   Scientists are experimenting with stem cells that can become Schwann cells (myelin-forming cells) or release helpful trophic factors around damaged nerves. In theory, they could support regeneration or slow damage. So far, work is largely in animal or lab models, and safety, long-term behavior, and dosing are not established for human CMT4B1. MDPI+2ResearchGate+2

4. General immune boosters
   For CMT4B1, which is not an autoimmune disease, there is no evidence that “immune-boosting” drugs help the underlying condition. Immune therapies like steroids or IVIG are used for autoimmune neuropathies, not for genetic demyelinating neuropathies such as CMT4B1. The best “immune support” here is timely vaccination, infection prevention, good nutrition, and sleep, not special drugs. ScienceDirect+1

---

Surgeries

Surgery in CMT4B1 does not fix the genetic problem or nerve damage. It is mainly used to correct bone and soft-tissue deformities to improve alignment, reduce pain, and make braces and shoes work better.

1. Soft-tissue release and tendon lengthening
   Over time, tight Achilles tendons and unbalanced foot muscles can pull the foot into a high-arched, inward-turned position. Surgeons can lengthen tight tendons and release contracted soft tissues. This can improve ankle motion and allow the foot to sit flatter in a brace or shoe. Recovery includes casting and physiotherapy. Muscular Dystrophy UK+3Physiopedia+3nhs.uk+3

2. Tendon transfer procedures
   In tendon transfer surgery, a working tendon is moved to help a weaker movement. For example, a tendon that lifts the toes may be redirected to assist ankle lifting, improving foot drop. This helps balance muscle forces and can make walking more stable and less tiring. Precise planning is needed so that donor muscles are strong enough to take on new roles. Physiopedia+2ScienceDirect+2

3. Osteotomy (bone-cutting) procedures
   For severe fixed deformities such as high arches or twisted heels, bone cuts may be needed to reshape the foot. Osteotomies reposition bones so the foot can bear weight more evenly. Plates, screws, or staples hold bones while they heal. This kind of surgery is usually considered only after conservative methods and bracing have been tried. nhs.uk+3nhs.uk+3Physiopedia+3

4. Arthrodesis (joint fusion)
   In very severe deformity or arthritis, fusing certain foot joints can create a stable, pain-reduced foot, even though movement in that joint is lost. The goal is a plantigrade (flat) foot that can fit in shoes and braces. NHS and expert guidelines describe arthrodesis as an option when other operations cannot maintain a functional foot position. nhs.uk+2nhs.uk+2

5. Spinal and other orthopedic surgeries
   Some people develop scoliosis (curved spine) or hip/knee deformities due to long-term muscle imbalance. Spinal fusion or joint surgery may be needed for severe deformity, pain, or nerve compression. These are major procedures and require careful risk–benefit analysis in a neuromuscular center. Physiopedia+2ScienceDirect+2

---

Prevention and lifestyle

Because CMT4B1 is a genetic condition, we cannot prevent the disease itself with lifestyle steps. But we can prevent or reduce complications:

1. Keep a healthy body weight to reduce stress on weak feet and ankles.

2. Do regular, safe exercise and stretching to preserve strength and joint movement.

3. Use appropriate braces and shoes early to avoid severe deformities and falls.

4. Protect the feet from injury by daily inspection and good foot care.

5. Avoid smoking, heavy alcohol use, and recreational drugs that can further damage nerves.

6. Check medicines with your neurologist to avoid those that worsen neuropathy.

7. Keep vaccinations up to date (e.g., influenza, COVID-19) to reduce serious illness that might reduce mobility.

8. Manage other conditions like diabetes or thyroid disease, which can add extra nerve or muscle problems.

9. Use home safety measures to prevent falls.

10. Seek early orthopedic and therapy input when new deformities or walking difficulties appear. Healthdirect+3nhs.uk+3Mayo Clinic+3

---

When to see a doctor urgently or for review

You should see, or take a child to, a doctor or neuromuscular specialist if:

• There is sudden worsening of weakness, walking, or hand use, different from the slow change usually seen in CMT.

• New symptoms appear, such as severe back pain, bladder or bowel problems, or sudden loss of feeling, which could suggest a different problem like nerve root compression.

• Pain becomes strong, constant, or stops responding to usual measures, especially at night.

• There are frequent falls, new fractures, or major balance problems.

• Foot sores, ulcers, or infections appear or are slow to heal.

• There are concerns about side effects of medicines, including mood changes, rash, swelling, or breathing changes.

• Planning surgery, pregnancy, or new high-risk activities that may need special advice.

Regular follow-up with a neurologist, physiotherapist, and orthopedist is recommended even when things seem stable. Mayo Clinic+2Muscular Dystrophy Association+2

---

What to eat and what to avoid

Because CMT4B1 affects nerves and muscles, diet should support overall health, weight control, and energy, even though no food can fix the gene change.

Helpful foods (what to eat)

1. Balanced meals with whole grains, fruits, and vegetables to provide fiber, vitamins, and antioxidants.

2. Lean protein such as fish, eggs, poultry, beans, and lentils to support muscle repair.

3. Calcium-rich foods (milk, yogurt, cheese, or fortified alternatives) and vitamin D–rich foods (oily fish, fortified milk) to help bones.

4. Sources of healthy fats like olive oil, nuts, seeds, and fish for heart and nerve cell membranes.

5. Enough water each day to avoid dehydration, which can worsen fatigue and cramps.

Foods and habits to limit or avoid

1. Very high-sugar foods and drinks, which promote weight gain and can raise diabetes risk, adding extra nerve damage.

2. Large amounts of saturated and trans fats from deep-fried foods and processed snacks, which harm heart and blood vessel health.

3. Excess alcohol, which is directly toxic to peripheral nerves and can worsen weakness and balance.

4. Heavy caffeine intake if tremor or sleep problems are present.

5. Crash diets or extreme supplement regimens that are not supervised by health professionals.

A registered dietitian familiar with neuromuscular diseases can create an individualized meal plan that respects culture, taste, and budget. nhs.uk+2Mayo Clinic+2

---

Frequently asked questions (FAQs)

1. Is CMT4B1 curable?
   No. At the moment, there is no cure for CMT4B1. Management is supportive and focuses on therapy, orthotics, surgery when needed, and symptom control. Research on gene therapy and other advanced treatments is ongoing but not yet available in routine care. MDPI+2ResearchGate+2

2. Does every person with CMT4B1 end up in a wheelchair?
   Not everyone. Many people continue to walk with braces or supports for many years. Some will need wheelchairs or scooters for longer distances, especially as they grow older or if the disease is severe from childhood. Early therapy and bracing can delay disability and improve independence. nhs.uk+2Muscular Dystrophy Association+2

3. Can exercise make the disease worse?
   Too much intense exercise can over-tire weak muscles, but moderate, well-planned exercise is usually helpful. It keeps joints flexible, muscles as strong as possible, and weight under control. A physiotherapist who knows about CMT should design the program. ScienceDirect+2Charcot-Marie-Tooth Disease+2

4. Are pain medicines like gabapentin or pregabalin safe for life-long use?
   These medicines can be used long-term when carefully monitored, but they have side effects like dizziness, weight gain, or swelling. Doctors may adjust dose, switch drugs, or add non-drug methods to keep doses as low as possible while still controlling pain. FDA Access Data+2NCBI+2

5. Is CMT4B1 an immune disease that needs steroids or IVIG?
   No. CMT4B1 is caused by a gene mutation in MTMR2, not by an immune attack. Steroids or IVIG are used for acquired immune neuropathies, not for inherited CMT types. Using strong immune drugs without a clear reason can cause harm. ZFIN+2Dove Medical Press+2

6. Can stem-cell therapy in private clinics cure CMT4B1?
   At present there is no proven, approved stem-cell treatment for CMT4B1. Some clinics advertise unproven “stem-cell cures,” but these are often very expensive and may be unsafe. Evidence-based research is still in early stages and should only be accessed through regulated clinical trials. MDPI+2AFM Téléthon+2

7. Can special diets like keto or gluten-free help the nerves?
   For most people with CMT4B1, there is no strong evidence that special fad diets improve nerve damage. However, if a person has another condition such as celiac disease, then gluten-free eating is necessary for that problem. In general, a balanced, sustainable diet is best.

8. Should family members have genetic testing?
   Often yes. Genetic testing can confirm whether siblings or other relatives are carriers or affected. This information can guide family planning and early monitoring. A genetic counselor and neurologist can advise which relatives should be tested and how results might affect them. ZFIN+1

9. Will my intelligence or thinking be affected?
   CMT4B1 mainly affects peripheral nerves, not the brain. Most people have normal thinking and learning abilities. School difficulties, if present, are usually due to fatigue, writing problems, or emotional stress rather than brain damage. Support at school can help a lot. Genetic Rare Diseases Center+1

10. How can I find clinical trials or expert centers?
    National rare disease organizations, neuromuscular clinics, and CMT foundations often list ongoing trials and specialist centers on their websites. Doctors can also check trial registries and refer patients. Joining a patient registry may help researchers contact you when suitable studies appear. MDPI+2ResearchGate+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 30, 2025.